D'Adamio Anthony's Form 4 filing
Bioventus Inc. (BVS) · filed Mar 16, 2023
- Accession no.
- 0000899243-23-008794
- Filed
- Mar 16, 2023
- Trade date
- Mar 14, 2022-Mar 15, 2023
- Filing delay
- 367 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.74K. It was filed 367 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| D'Adamio AnthonyCIK 0001835184 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Class A Common Stock | MOption exerciseAcquired | +8,887 | – | – | 49,019 | Direct | |
| Mar 15, 2023 | Class A Common Stock | SSaleDisposed | −3,409 | $1.39 | −$4,738.51 | 45,610 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Class A Common Stock | AGrant or awardAcquired | +35,545 | $0.00 | $0 | 35,545 | Direct | |
| Mar 14, 2023 | Class A Common Stock | MOption exerciseDisposed | −8,887 | $0.00 | $0 | 26,658 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.